equis - Articles
Firocoxib
Introduction
Name
- Firocoxib.
Class of drug
- Non-stroidal anti-inflammatory drug.
- Coxib class.
Description
Chemical name
- 3-(Cyclopropylmethoxy)-5,5-dimethyl-4-(4-methylsulfonylphenyl)furan-2-one.
Molecular formula
- C17H20O5S.
Molecular weight
- 336.402 g.
Physical properties
- Solution for injection is clear and colorless, containing 20 mg/ml firocoxib.
- Oral paste is white to off-white.
- Each gram contains 8.2 mg firocoxib.
Storage requirements
- Below 30°C; brief excursions up to 40°C are reported to be acceptable.
- Solution for injection should be discarded after 1 month of opening.
- Syringe for oral administration should be discarded after 3 months of opening.
Uses
Subscribe To View
This article is available to subscribers.
Try a free trial today or contact us for more information.
Administration
Subscribe To View
This article is available to subscribers.
Try a free trial today or contact us for more information.
Pharmacokinetics
Subscribe To View
This article is available to subscribers.
Try a free trial today or contact us for more information.
Precautions
Subscribe To View
This article is available to subscribers.
Try a free trial today or contact us for more information.
Withdrawal Periods
Subscribe To View
This article is available to subscribers.
Try a free trial today or contact us for more information.
Adverse Reactions
Subscribe To View
This article is available to subscribers.
Try a free trial today or contact us for more information.
Further Reading
Publications
Refereed papers
- Recent references from PubMed and VetMedResource.
- Knych H K et al (2014) Detection and pharmacokinetics of three formulations of firocoxib following multiple administrations to horses. Equine Vet J 46 (6), 734 PubMed.
- Hilton H G et al (2011) Distribution of flunixin meglumine and firocoxib into aqueous humor of horses. J Vet Intern Med 25 (5), 1127-1133 PubMed.
- Koene M et al (2010) Field trial validation of the efficacy and acceptability of Firocoxib, a highly selective COX-2 inhibitor, in a group of 96 lame horses. J Eq Vet Sc 30 (5), 237-243 VetMedResource.
- Back W, MacAllister C G & van Heel M C V et al (2009) The use of force plate measurements to titrate the dosage of a new COX-2 inhibitor in lame horses.Equine Vet J 41 (3), 309-312 PubMed.
- Cook V L, Meyer C T, Campbell N B & Blikslager A T (2009) Effect of firocoxib or flunixin meglumine on recovery of ischemic-injured equine jejunum. Am J Vet Res 70 (8), 992-1000 PubMed.
- Dutton D W, Lashnits K J & Wegner K (2009) Managing severe hoof pain in a horse using multimodal analgesia and a modified composite pain scale. Equine Vet Educ 21 (1), 37-43 Wiley.
- Doucet M Y, Bertone A L, Hendrickson D et al (2008) Comparison of efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritis. JAVMA 232 (1), 91-97 PubMed.
- Letendre L T, Tessman R K, McClure S R et al (2008) Pharmacokinetics of firocoxib after administration of multiple consecutive daily doses to horses. Am J Vet Res 69 (11), 1399-1405 PubMed.
- McConnico R S, Morgan T W, Williams C C, Hubert J D & Moore R M (2008) Pathophysiologic effects of phenylbutazone on the right dorsal colon in horses. Am J Vet Res 69 (11), 1496-1505 PubMed
- Kvaternick V, Pollmeier M, Fischer J et al (2007) Pharmacokinetics and metabolism of orally administered Firocoxib, a novel second-generation coxib, in horses. J Vet Pharm Ther 30 (3), 208-217 PubMed.
Other sources of information
- Plumb D C (2011) Veterinary Drug Handbook. 7th edn. Wiley-Blackwell, USA.
- Hanson P D & Maddison J E (2008) Nonsteroidal anti-inflammatory drugs and chondroprotective agents. In: Small Animal Clinical Pharmacology. Eds: Maddison J E & Page S W & Church D B Saunders Elsevier, USA. pp 287-309.
- Equioxx® (firocoxib) product information - Website: www.equioxx.com.